Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ana Paula de Torres Santos, Vanessa Cristina Martins Silva, Maria Cássia Mendes-Corrêa, Marcilio Figueiredo Lemos, Fernanda de Mello Malta, Rúbia Anita Ferraz Santana, Gregório Tadeu Fernando Dastoli, Vanessa Fusco Duarte de Castro, João Renato Rebello Pinho & Regina Célia Moreira. (2021) Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, Brazil. Infection and Drug Resistance 14, pages 723-730.
Read now
Read now
Martina Properzi, Paola Magro, Francesco Castelli & Eugenia Quiros-Roldan. (2018) Dolutegravir-rilpivirine: first 2-drug regimen for HIV-positive adults. Expert Review of Anti-infective Therapy 16:12, pages 877-887.
Read now
Read now
Articles from other publishers (7)
Xiaogang Liu, Shiye Wu, Zitong Zhu, Ying Wang & Binquan Gou. (2022) Virtual screening for finding inhibitor against the main protease of SARS-Cov-2 from the FDA-approved drugs database. Virtual screening for finding inhibitor against the main protease of SARS-Cov-2 from the FDA-approved drugs database.
Ahmed Elsanhoury, Sophie Van Linthout & Carsten Tschöpe. 2020. Myocarditis. Myocarditis
297
316
.
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak & Anna Jelińska. (2019) Hepatitis C – New drugs and treatment prospects. European Journal of Medicinal Chemistry 165, pages 225-249.
Crossref
Crossref
Monjur Ahmed. (2018) Era of direct acting anti-viral agents for the treatment of hepatitis C. World Journal of Hepatology 10:10, pages 670-684.
Crossref
Crossref
Jürgen Krauß & Franz Bracher. (2018) Pharmacokinetic Enhancers (Boosters)—Escort for Drugs against Degrading Enzymes and Beyond. Scientia Pharmaceutica 86:4, pages 43.
Crossref
Crossref
Fabrizio Fabrizi, Francesca M. Donato & Piergiorgio Messa. (2017) Direct-acting Antivirals for Hepatitis C Virus in Patients on Maintenance Dialysis. The International Journal of Artificial Organs 40:10, pages 531-541.
Crossref
Crossref
Rebecca Lee, Shyam Kottilil & Eleanor Wilson. (2016) Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy. Hepatology International 11:2, pages 161-170.
Crossref
Crossref